Aug 2026· Genomics, Proteomics & Bioinformatics· 0 citations
Medicine
TL;DR
A novel multi-modal deep learning model with intermediate fusion: multi-omics fusion neural network- computational cell counting (MOFUN-CCC) designed to predict absolute cell counts directly by integrating gene expression and DNA methylation data within a supervised framework, assuming that the underlying true cell components are shared across the two omics data.
Abstract
As the volume of omics data continues to grow exponentially, there is an increasing demand for innovative methodologies that combine multi-omics data to extract meaningful clinical insights. Absolute cell counts are a fundamental component of clinical evaluations for disease diagnosis, treatment, and patient management. While cellular deconvolution can estimate relative cell type proportions from bulk data, obtaining absolute cell counts from omics data remains rarely studied. In response to the clinical needs and challenges, we introduce a novel multi-modal deep learning model with intermediate fusion: multi-omics fusion neural network- computational cell counting (MOFUN-CCC). This model is designed to predict absolute cell counts directly by integrating gene expression and DNA methylation data within a supervised framework, assuming that the underlying true cell components are shared across the two omics data. Comprehensive evaluations, including cross-validation, independent data testing, and real-world applications, demonstrate the model's robustness, precision, and capacity to effectively capture biological variations. MOFUN-CCC represents a pioneering effort in the integration of multi-omics data for the prediction of absolute cell counts. With our user-friendly software (https://github.com/yuemolin/MOFUN-CCC) and web application (https://shiny.crc.pitt.edu/mofun_shiny/), this innovation holds the potential to make significant contributions to disease diagnosis, progression analysis, and clinical decision-making.
This work reports Pathway Activity Autoencoders for the multi-omics setting, which embed prior knowledge via pathway-informed architectural constraints, fostering interpretability, while preserving representational power, in the context of breast cancer.
Pedro Henrique da Costa Avelar, L. Ou-Yang, Min Wu et al.· 0 citations
Per-dataset analysis reveals three reproducible regimes: probabilistic variational autoencoder variants help on the smallest datasets, deep autoencoders win on mid-scale data with multi-batch or many-type structure, and classical PCA pipelines remain competitive when linear projection already captures the dominant vari...
Phong T. Nguyen, T. Vu, T. Nguyen et al.· arXiv.org· 0 citations
ProphDR is an interpretable deep learning framework that integrates multiomics data and drug structural information using a hierarchical attention mechanism, and generates biologically interpretable attention maps that highlight key pharmacophores and resistance-related genes consistent with established mechanisms in N...
Yundian Zeng, Qing Ye, Jike Wang et al.· Journal of Chemical Informat...· 0 citations
A modality-aware comparative framework that enables direct, side-by-side evaluation of clinical-only, metabolomics-only, and combined modeling strategies within a unified pipeline, and reveals that the dominant contributing modality shifted by scenario, reflecting differences in disease context.
K. Wanichthanarak, Kassaporn Duangkumpha, Nichapa Kleebkomut et al.· ACS Measurement Science Au· 0 citations
MB-SupCon-cont improves prediction accuracy by incorporating a generalized contrastive loss function that defines similarity and dissimilarity for continuous responses using three distance-based weighting methods, and provides superior representation learning and improves data visualization in lower-dimensional spaces.
Sen Yang, Shidan Wang, Yiqing Wang et al.· Frontiers in microbiomes· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.